TVS Motor Company reported a 23.5% rise in quarterly profit to Rs 663 crore, missing estimates. The company faced higher costs despite stable demand. Revenue rose 13.3% to Rs 9228 crore but fell short of projections. EV sales saw a 31% increase, while two-wheeler sales grew 15% year-over-year.
Stock Market LIVE Updates: Sensex muted at 80,100; Nifty at 24,450; FMCG down 2%, PSB gains 1.5% (24-10-2024)
Stock Market Live: Benchmark Indian equity indices BSE Sensex and Nifty 50 were trading on a muted note after opening higher on Thursday
F&O Ban List: NMDC, RBL Bank among 10 stocks under trade ban on Thursday (24-10-2024)
Ten stocks, including Aarti Industries and Bandhan Bank, are under ban from F&O trading as their open interest exceeded 95%. This ban will only be lifted if their open interest drops below 80%. The Indian benchmark indices S&P BSE Sensex and Nifty ended lower on Wednesday amid volatile trading, foreign fund outflows, and selling pressure.
Stocks to Watch, Oct 24: HUL, AU Small Fin Bank, Piramal Ent, Pidilite Ind (24-10-2024)
Stocks to Watch, Oct 24, 2024: In Q2FY25, HUL reported a consolidated revenue increase of 1.93 per cent to Rs 15,926 crore YoY, while Ebitda saw a slight decline of 0.1 per cent
Q2 results today: ITC, Adani Wilmar among 114 companies to announce earnings on Thursday (24-10-2024)
Today, 114 companies, including ITC, IndusInd Bank, and Godrej Consumer, will announce their second-quarter earnings for July-September 2024. ITC is expected to see modest growth in revenue and profit, while IndusInd Bank may see a slight dip in net profit despite some growth in net interest income.
Big movers on D-Street: What should investors do with HUL, SBI Life and TVS Motor? (24-10-2024)
Benchmark Sensex declined 138 points as investors booked profits amid ongoing FPI outflows, marking its third day of losses. HUL formed a bullish pattern at lower levels, SBI Life showed reversal signs, while TVS Motor indicated further downside.
Aster DM Healthcare reports consolidated net profit of Rs 96.84 crore in the September 2024 quarter (24-10-2024)
Sales rise 16.89% to Rs 1086.44 crore
Shrem InvIT consolidated net profit rises 7.55% in the September 2024 quarter (24-10-2024)
Sales rise 10.32% to Rs 488.74 crore
Piramal Pharma consolidated net profit rises 350.00% in the September 2024 quarter (24-10-2024)
Sales rise 17.28% to Rs 2241.75 crore